CHAPTER 30
Pharmaceutical Products
Section VI of the U.S. Harmonized Tariff Schedule. 6 headings.
Headings in this chapter
3001
Glands and other organs for organotherapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organotherapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included:
3002
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified:
3003
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale:
3004
Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale:
3005
Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes:
3006
Pharmaceutical goods specified in note 4 to this chapter:
Recent CBP rulings in Chapter 30
N361639
May 26, 2026
The tariff classification of Nintedanib Capsules in dosage form, from India
N361128
May 19, 2026
The country of origin of infrared forehead thermometers
N361037
May 18, 2026
The tariff classification and country of origin of Naltrexone Hydrochloride Tablets in dosage form
N360873
May 15, 2026
The tariff classification of Testosterone Gel in dosage form, from China
N360453
May 6, 2026
The tariff classification of Brivaracetam Oral Solution in dosage form, from India
N360491
May 6, 2026
The tariff classification of Glucagon Injection in dosage form, from Switzerland
N360493
May 6, 2026
The tariff classification of Colestipol Hydrochloride Tablets in dosage form, from Taiwan
N360246
April 29, 2026
The tariff classification of Doxorubicin Hydrochloride Liposome Injection in dosage form, from Germany
N360371
April 29, 2026
The tariff classification of Sugammadex Injection in dosage form, from India
N360180
April 28, 2026
The tariff classification of Brimonidine Tartrate and Timolol Maleate Ophthalmic Drops 0.2%/0.5% in dosage form, from India
N360214
April 28, 2026
The tariff classification of Bumetanide Tablets in dosage form, from India
N360217
April 28, 2026
The tariff classification of Bumetanide Tablets in dosage form, from Italy
Chapter 30 legal notes →
Section, chapter, additional U.S., and statistical notes that govern classification under Chapter 30.
Classifying products in Chapter 30?
TariffLens classifies your products with GRI reasoning, cited CBP rulings, and audit-ready documentation.
Book a demo →